Skip to main content
SpringerLink
Log in

Rheumatoid Arthritis and Related Disorders

Family Medicine

  • 1666 Accesses

Abstract

Joint pain is a common complaint in primary care. Pain can be considered acute (days), subacute (weeks), or chronic (generally lasting more than 6 weeks). Accurately diagnosing the cause of joint pain, encouraging continuity of care, and working with multidisciplinary teams using the right blend of therapeutic modalities gives patients the best chance for good long-term outcomes. This chapter will focus, in particular, on diseases that commonly present with joint pain.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Nell VPK, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004;43(7):906–14.

    Article  CAS  PubMed  Google Scholar 

  2. Ahlmén M, Svensson B, Albertsson K, Forslind K, Hafström I. Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann Rheum Dis. 2010;69(1):230–3.

    Article  PubMed  Google Scholar 

  3. Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1995–2007. Arthritis Rheum. 2010;62(6):1576–82.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kelly C, Hamilton J. What kills patients with rheumatoid arthritis? Rheumatology. 2007;46(2):183–4.

    Article  CAS  PubMed  Google Scholar 

  5. Fuller-Thomson E, Liddycoat JP, Stefanyk M. The association between a history of parental addictions and arthritis in adulthood: findings from a representative community survey. Int J Popul Res. 2014. doi:10.1155/2014/582508.

    Google Scholar 

  6. Barton A, Worthington J. Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis Rheum. 2009;61(10):1441–6.

    Article  CAS  PubMed  Google Scholar 

  7. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.

    Article  PubMed  Google Scholar 

  8. Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. Q J Med. 2007;100:193–201.

    Article  CAS  Google Scholar 

  9. Rizzo C, Ceccarelli F, Gattamelata A, et al. Ultrasound in rheumatoid arthritis. Med Ultrason. 2013;15(3):199–208.

    Article  PubMed  Google Scholar 

  10. Quan L, Thiele GM, Tian J, Wang D. The development of novel therapies for rheumatoid arthritis. Expert Opin Ther Pat. 2008;18(7):723–38. doi:10.1517/13543776.18.7.723.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64(5):625–39.

    Article  CAS  Google Scholar 

  12. Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011;63(3):573–86.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Arvonen M, Virta LJ, Pokka T, et al. Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this groups’ greater susceptibility to infections? J Rheumatol. 2015;42(3):521–6.

    Article  PubMed  Google Scholar 

  14. Petty RE, Southwood TR, Manners P, International League of Associations for Rheumatology, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.

    PubMed  Google Scholar 

  15. Cassidy J, Kivlin J, Lindsley C, Nocton J. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006;117(5):1843–5.

    Article  PubMed  Google Scholar 

  16. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, Dewitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465–82.

    Article  Google Scholar 

  17. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am. 2009;35(1):21–44.

    Article  PubMed  Google Scholar 

  18. Kim PS, Klausmeier TL, Orr DP. Reactive arthritis: a review. J Adolesc Health. 2009;44(4):309–15.

    Article  PubMed  Google Scholar 

  19. Rudwaleit M, Braun J, Sieper J. Treatment of reactive arthritis: a practical guide. BioDrugs. 2000;13(1):21–8.

    Article  CAS  PubMed  Google Scholar 

  20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

    Article  CAS  PubMed  Google Scholar 

  21. Ainila H, Hietaharju A, Loukkola J. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Care Res. 2001;45(5):419–23.

    Article  Google Scholar 

  22. Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics. Ann Rheum Dis. 2008;67(2):195–205.

    Article  CAS  PubMed  Google Scholar 

  23. Hahn BV, McMahon M, Wilkinson A, et al. American College of Rheumatology guidelines for screening, case definition, treatment and management of lupus nephritis. Arthritis Care Res. 2012;64(6):797–808.

    Article  Google Scholar 

  24. Gayraud M. Raynaud’s phenomenon. Joint Bone Spine. 2007;74(1):e1–8.

    Article  PubMed  Google Scholar 

  25. Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol. 2012;8(8):469–79.

    Article  CAS  PubMed  Google Scholar 

  26. Ennis H, Anderson ME, Wilkinson J, Herrick AL. Calcium channel blockers for primary Raynaud’s phenomenon. Cochrane Database Syst Rev. 2014;1:CD002069.

    PubMed  Google Scholar 

  27. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–47.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity. 2005;38(2):113–6.

    Article  CAS  PubMed  Google Scholar 

  29. Hissaria P, Roberts-Thomson PJ, Lester S, Ahern MJ, Smith MD, Walker JG. Cigarette smoking in patients with systemic sclerosis – reduces overall survival. Arthritis Rheum. 2011;63(6):1758–9.

    Article  CAS  PubMed  Google Scholar 

  30. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Gálvez J, Sáiz E, López P, Pina MA, Carrillo A, Nieto A, et al. Diagnostic evaluation and classification criteria in Sjögren’s syndrome. Joint Bone Spine. 2008;76(1):44–49.

    Google Scholar 

  32. Thanou-Stavraki A, James JA. Primary Sjogren’s syndrome: current and prospective therapies. Semin Arthritis Rheum. 2008;37(5):273–92.

    Article  CAS  PubMed  Google Scholar 

  33. Meijer JM, Pijpe J, Vissink A, Kallenberg CG, Bootsma H. Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment. Ann Rheum Dis. 2009;68(2):284–5.

    Article  CAS  PubMed  Google Scholar 

  34. Caylor TL, Perkins A. Recognition and management of polymyalgia rheumatica and giant cell arteritis. Am Fam Physician. 2013;88(10):676–84.

    PubMed  Google Scholar 

  35. Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatic: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484–92.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Ghosh P, Borg FA, Dasgupta B. Current understanding and management of giant cell arteritis and polymyalgia rheumatica. Expert Rev Clin Immunol. 2010;6(6):913–28.

    Article  CAS  PubMed  Google Scholar 

  37. Hernández-Rodríguez J, Cid MC, López-Soto A, Espigol-Frigolé G, Bosch X. Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med. 2009;169(20):1839–50.

    Article  PubMed  Google Scholar 

  38. Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum. 2004;33(5):294–301.

    Article  PubMed  Google Scholar 

  39. Waldman CW, Waldman SD, Waldman RA. Giant cell arteritis. Med Clin North Am. 2013;97(2):329–35.

    Article  PubMed  Google Scholar 

  40. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.

    Article  CAS  PubMed  Google Scholar 

  41. Dasgupta B. Giant Cell Arteritis Development Group. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med. 2010;10(4):381–6.

    Article  PubMed  Google Scholar 

  42. van der Linden S, van der Heijde D. Ankylosing spondylitis. Clinical features. Rheum Dis Clin N Am. 1998;24(4):663–76.

    Article  Google Scholar 

  43. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol. 2001;13(4):265–72.

    Article  CAS  PubMed  Google Scholar 

  44. Moll JM, Wright V. New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis. 1973;32(4):354–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Goie HS, Steven MM, van der Linden SM, et al. Evaluation of diagnostic criteria for anklyosing spondylitis: a comparison of Rome, New York and modified New York criteria in patients with a positive clinical screening test for ankylosing spondylitis. Br J Rheumatol. 1985;24(3):242–9.

    Article  Google Scholar 

  46. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379–90.

    Article  PubMed  Google Scholar 

  47. Ali A, Samson CM. Seronegative spondyloarthropathies and the eye. Curr Opin Ophthalmol. 2007;18(6):476–80.

    Article  PubMed  Google Scholar 

  48. van der Heijde D, Landewé R. Imaging in spondylitis. Curr Opin Rheumatol. 2005;17(4):413–7.

    Article  PubMed  Google Scholar 

  49. Escalas C, Trijau S, Dougados M. Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysis. Rheumatology (Oxford). 2010;49(7):1317–25.

    Article  CAS  Google Scholar 

  50. Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev. 2008;(1):CD002822.

    Google Scholar 

  51. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73.

    Article  PubMed  Google Scholar 

  52. Fitzgerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 2009;11(1):214.

    Article  PubMed Central  PubMed  Google Scholar 

  53. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm390091.htm. Accessed 9 Mar 2015.

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, C1094, Bethesda, MD, 20814-4799, USA

    Mark B. Stephens

  2. Associate Dean for Medical Education, F. Edward Hebert School of Medicine, Uniformed Services, University of the Health Sciences, Bethesda, MD, 20814-4799, USA

    William R. Gilliland

Authors
  1. Mark B. Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William R. Gilliland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark B. Stephens .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska, Omaha, Nebraska, USA

    Paul Paulman

  2. Virginia Beach, Virginia, USA

    Robert Taylor

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland (outside the USA)

About this entry

Cite this entry

Stephens, M.B., Gilliland, W.R. (2015). Rheumatoid Arthritis and Related Disorders. In: Paulman, P., Taylor, R. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-1-4939-0779-3_120-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0779-3_120-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-1-4939-0779-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Rheumatoid Arthritis and Related Disorders
    Published:
    11 June 2020

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_120-2

  2. Original

    Rheumatoid Arthritis and Related Disorders
    Published:
    23 May 2015

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_120-1

Search

Navigation